MELBOURNE, Australia and INDIANAPOLIS, March 10, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces ...
Shares rebound from Monday’s $90b wipeout; oil back to $US90 after earlier surge toward $120; Fortescue completes Alta buy; Air New Zealand axes guidance over conflict. Follow live.
Hosted on MSN
Why is this ASX 200 share charging 7% higher today?
Clarity Pharmaceuticals Ltd (ASX: CU6) shares are having a strong session on Tuesday. At the time of writing, the ASX 200 share is up 7% to $3.52 after the company released a clinical trial update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results